Risk of T-cell Malignancy Following CAR T cells in Children, Adolescents and Young Adults

Adam J. Lamble,Liora M. Schultz,Khanh Nguyen,Emily M Hsieh,Kevin McNerney,Rayne H Rouce,Rebecca A Gardner,Sara Ghorashian,Nirali N Shah,Shannon L. Maude

Blood Advances（2024）

引用 0|浏览2

暂无评分

摘要

Our global survey reveals no cases of insertional mutagenesis following CAR T-cells in pediatric patients challenging concerns of secondary malignancy risk in this population. This underscores the safety of CAR T-cell therapy in this population, but ongoing surveillance required.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要